Is DYADIC INTERNATIONAL INC (DYAI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 18.2% / 30% | 33.3% / 30% | 0.9% / 30% | 13.07% / 5% | ✗ NOT HALAL |
| DJIM | 18.2% / 33% | 33.3% / 33% | 0.9% / 33% | 13.07% / 5% | ✗ NOT HALAL |
| MSCI | 51.0% / 33% | 93.3% / 33% | 2.6% / 33% | 13.07% / 5% | ✗ NOT HALAL |
| S&P | 18.2% / 33% | 33.3% / 33% | 0.9% / 33% | 13.07% / 5% | ✗ NOT HALAL |
| FTSE | 51.0% / 33% | 93.3% / 33% | 2.6% / 50% | 13.07% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 24.9% | |
| Operating Margin | -269.6% | |
| Net Margin | -238.3% | |
| Return on Equity (ROE) | -397.8% | |
| Return on Assets (ROA) | -44.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$4M |
| Free Cash Flow | -$4M |
| Total Debt | $5M |
| Debt-to-Equity | 410.6 |
| Current Ratio | 2.7 |
| Total Assets | $10M |
Price & Trading
| Last Close | $0.70 |
| 50-Day MA | $0.83 |
| 200-Day MA | $0.95 |
| Avg Volume | 65K |
|
52-Week Range
$0.65
| |
About DYADIC INTERNATIONAL INC (DYAI)
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is DYADIC INTERNATIONAL INC (DYAI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), DYADIC INTERNATIONAL INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is DYADIC INTERNATIONAL INC's debt ratio?
DYADIC INTERNATIONAL INC's debt ratio is 18.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 51.0%.
What are DYADIC INTERNATIONAL INC's key financial metrics?
DYADIC INTERNATIONAL INC has a market capitalization of $25M, and revenue of $3M. The company maintains a gross margin of 24.9% and a net margin of -238.3%. Return on equity stands at -397.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.